BTIG Reiterates Buy Rating on ProKidney Corp. (PROK)
Tweet Send to a Friend
BTIG analyst Justin Zelin reiterated a Buy rating and $6.00 price target on ProKidney Corp. (NASDAQ: PROK).The analyst commented, "PROK ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
